Whalesbook
📉 The Financial Deep Dive
Nath Bio-Genes (India) Limited has unveiled its financial results for the third quarter and nine months ended December 31, 2025, revealing a significant divergence in performance between its standalone and consolidated operations, compounded by a critical auditor's note.
The Numbers:
On a standalone basis, the company posted a robust 78.8% YoY increase in Revenue from operations, reaching ₹6596.11 Lakhs in Q3 FY2026. This stellar top-line growth was accompanied by a substantial 172.4% YoY surge in Profit After Tax (PAT), which climbed to ₹723.08 Lakhs from ₹265.50 Lakhs in the prior year. The PAT growth was amplified by a considerable jump in 'Other Income' (₹173.56 Lakhs vs ₹47.82 Lakhs) and the recognition of exceptional items amounting to ₹268.60 Lakhs. Consequently, Basic Earnings Per Share (EPS) improved from ₹1.40 to ₹3.80.
For the nine months ended December 31, 2025, standalone revenue grew 23.3% YoY to ₹38590.36 Lakhs, with PAT rising 13.2% YoY to ₹4463.77 Lakhs. Exceptional items of ₹474.94 Lakhs contributed to this nine-month period's profit.
The Quality & The Grill:
However, the consolidated financial picture presented a stark contrast. While consolidated Revenue from operations also mirrored the standalone growth at 78.8% YoY to ₹6595.90 Lakhs for Q3 FY2026, the consolidated PAT declined by a significant 39.4% YoY to ₹160.49 Lakhs from ₹265.05 Lakhs in Q3 FY2025. This led to a sharp contraction in the consolidated PAT margin, from 7.20% to 2.43%.
For the nine months ended December 31, 2025, consolidated revenue grew 22.5% YoY to ₹38350.87 Lakhs. Consolidated PAT saw a more modest growth of 12.2% YoY to ₹4163.92 Lakhs. The consolidated figures also include the aforementioned 'Other Income' and exceptional items.
A major point of concern is the auditor's qualified opinion on both standalone and consolidated limited review reports. The auditors could not assess the financial impact of changes in India's Labour Codes effective November 21, 2025. Consequently, no provision has been made for potential increased liabilities related to employee benefits, and the extent of adjustments required could not be determined due to the absence of actuarial valuation or reliable estimates. This lack of clarity significantly impacts the reliability of the reported profit figures.
🚩 Risks & Outlook:
The primary risk highlighted is the unquantified liability arising from the new Labour Codes. Investors must monitor developments and the company's progress in obtaining actuarial valuations. The significant difference between standalone PAT and consolidated PAT warrants deeper investigation into subsidiary performance and inter-company transactions.
Future performance will depend on the company's ability to navigate the regulatory changes, sustain its strong standalone revenue growth, and provide clarity on the consolidated earnings impact. The market will be watching for any updates on the Labour Code assessment in subsequent filings.